We decided to further investigate Drp1 in thyroid tumors’ oncocytic phenotype because we observed a statistically significant increase of Drp1 protein, both in oncocytic tumors and in the oncocytic cell line, and because of the known involvement of this protein in breast cancer malignancy[31]. This evidence concerns the gene DNM1L and thyroid tumor.